SRF Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of SRF Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: SRF Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news and updates on SRF Ltd. from all sources in a single place.

SRF Ltd.

25 Nov 2025, 07:14PM

2793.80

-0.49%

Company Update

SRF Ltd - 503806 - Intimation Of Grant Of Options Under 'Part A - SRF Employees …

BSE India

Intimation of Grant of Options under ''Part-A- SRF Employees Stock Option Scheme, 2018 of SRF Long term Share based Incentives Plan, 2018 of the Company

pdf

SRF Ltd.

18 Nov 2025

2793.80

-0.49%

5 stocks to avoid in current market; SRF, Devyani, 3 more may dip up to 15%

Business Standard

SRF, Devyani, Sumitomo have witnessed the formation of 'Death Cross', while Sona Coms and PI Industries saw a negative crossover on the MACD indicator, show the stocks daily chart.

SRF Ltd. is trading below all available SMAs

SRF Ltd.

04 Nov 2025

2793.80

-0.49%

Earnings Call

SRF Ltd - 503806 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Earnings Call held on 28th October 2025

pdf

SRF Ltd.

03 Nov 2025

2793.80

-0.49%

SAST

SRF Ltd - 503806 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund

pdf

SRF Ltd.

31 Oct 2025

2793.80

-0.49%

SRF Ltd.

Buy: SRF Ltd.

Target

ICICI Direct

Q2FY26 Chemicals Business drives growth- Revenues grew 6% YoY to 3,534.5 crore driven by the Chemicals business (46% of the revenues) which reported a growth of 23% YoY to 1,667 crore. While technical textiles (13% of the revenue) and Packaging films (39% of revenues) reported a decline of 11% and 1% to 474.3 crore and 1,408 crore respectively. Consolidated EBITDA stood at 774.2 crore, up 44% YoY, translating to margins of 21.3%, up ~560 bps YoY driven by the Chemical business (EBIT) which stood at 29%, up ~1100 bps YoY. Moreover, PAT for...

Number of FII/FPI investors increased from 670 to 679 in Sep 2025 qtr.

SRF Ltd.

29 Oct 2025

2793.80

-0.49%

'Hold' SRF Shares Maintains Systematix Post Mixed Q2 Result, Trims Target Price; Sees Limited Upside Potential

NDTV Profit

While chemicals Ebit held the operating performance in line, the huge drag in packaging films business disappointed, adds the brokerage.

SRF Ltd. has an average target of 3294.89 from 10 brokers.

SRF Ltd.

29 Oct 2025

2793.80

-0.49%

SRF's chemicals biz leads Q2 growth; analysts stay bullish; check targets

Business Standard

Brokerages maintained a positive stance on SRF, highlighting continued margin strength, steady volume growth, and the company's strategic capex expansion.

Number of FII/FPI investors increased from 670 to 679 in Sep 2025 qtr.

SRF Ltd.

29 Oct 2025

2793.80

-0.49%

BP Equities Q2FY26 Result Update SRF Ltd

Results Update: SRF Ltd.

BP Wealth

...

SRF Ltd. has gained 25.65% in the last 1 Year

SRF Ltd.

29 Oct 2025

2793.80

-0.49%

SRF: Q2FY26 Result Review

Buy: SRF Ltd.

Recommendation Target

IDBI Capital

SRF delivered results in line with our expectations primarily owing to healthy performance in specialty chemicals and higher pricing of refrigerant gases. Higher volumes especially in HFCs also contributed to the growth. While Revenue grew by 6% YoY, EBITDA and PAT grew by impressive rates of 44% and 93% respectively. The chemicals business registered strong revenue growth of 23% YoY along with ~1080 bps of YoY margin improvement to 28.9%. Although some orders have been deferred on the agro side, we expect SRF to recoup the same in H2FY26. The Fluorochemicals part of the business was elevated by...